In 2019, the first CRISPR clinical trials were conducted to treat sickle cell diseases and in 2020, this treatment was ...

RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

A little-known Chinese biotech startup has zipped ahead of US companies in one of the gene editing field’s most competitive ...

Intellia Therapeutics has dosed the first subject in the Phase III trial of NTLA-2002, to treat hereditary angioedema (HAE).

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.A novel ...

Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.